KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Resmed (RMD) Enterprise Value (2016 - 2025)

Historic Enterprise Value for Resmed (RMD) over the last 17 years, with Q4 2025 value amounting to -$1.4 billion.

  • Resmed's Enterprise Value fell 17149.83% to -$1.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.4 billion, marking a year-over-year decrease of 17149.83%. This contributed to the annual value of -$1.2 billion for FY2025, which is 40740.26% down from last year.
  • As of Q4 2025, Resmed's Enterprise Value stood at -$1.4 billion, which was down 17149.83% from -$1.4 billion recorded in Q3 2025.
  • Over the past 5 years, Resmed's Enterprise Value peaked at -$194.5 million during Q4 2021, and registered a low of -$1.4 billion during Q4 2025.
  • Over the past 5 years, Resmed's median Enterprise Value value was -$245.8 million (recorded in 2022), while the average stood at -$458.8 million.
  • As far as peak fluctuations go, Resmed's Enterprise Value soared by 3624.65% in 2021, and later crashed by 40740.26% in 2025.
  • Quarter analysis of 5 years shows Resmed's Enterprise Value stood at -$194.5 million in 2021, then tumbled by 30.2% to -$253.2 million in 2022, then grew by 16.96% to -$210.2 million in 2023, then crashed by 148.25% to -$521.9 million in 2024, then crashed by 171.5% to -$1.4 billion in 2025.
  • Its Enterprise Value was -$1.4 billion in Q4 2025, compared to -$1.4 billion in Q3 2025 and -$1.2 billion in Q2 2025.